Agetech

Early intervention and disease prevention = Longevity

Talking prevention and treatments for Longevity with Prodrome's Dayan Goodenowe. Detecting prodromes – an early indication of a developing condition or disease – could revolutionise...

Home alone: extend life while saving life

Most of us are at home right now - what will it be like when we're older? And what is being done to improve...

Some good news: announcing Longevity2020

In these challenging times, with everyone working from home and conferences pushed-back to later this year, we had an idea: Longevity2020 While the world overcomes...

Talking Longevity investment and risk with R42 Group

Longevity investment is growing and we're seeing a mixture of funds and investment platforms. We chat with the founder of R42 Group. R42 Group actively invents...

Time banking: helping others to help yourself

Time banking is an opportunity for everyone in an aging society but also a lesson for everyone at times of global epidemic: help others...

Wired for sound: neuroceutical boosts immunity

Smartphone neuroceutical app harnesses the brain's quantum state to boost the immune system in the fight against aging. Quantum mechanics, the motion and interaction of...

AI home monitoring tech wins Home of 2030 award

With things looking increasingly grim out there, some good news arrived in our inbox from one of the companies we covered recently: Kemuri takes...

An operating system for senior living

K4Connect aims to create a smart OS for senior living with a single interface for all technologies. Technology adoption among older adults has been consistently...

Metabolic aging, fasting and metformin

The presence of a “metabolic clock” that regulates aging involves the accumulation of metabolic alterations and a decline in metabolic homeostasis and biological fitness. An...

AI and machine vision addresses falls prevention

VirtuSense uses machine vision and AI to address the multi-million falls prevention market opportunity. According to the U.S. Centers for Disease Control and Prevention, falls...

Upgrade Labs: the Longevity clinic of the future?

One of the leaders in health and nutrition came to our London office to talk biohacking, investing, big data and neuroceuticals. Longevity remains open to...

VR for brain training and tracking cognitive health

Virtuleap currently fundraising to build headcount and capitalise on cognitive illness detection algorithms. Ever since the US Federal Trade Commission fined Lumosity $2 million for...

Megatrends: longer lives and finance sector disruption

Financing Longevity means getting to grips with a collision of megatrends and surfing the Silver Tsunami. In the second of our two-part interview with Margaretta Colangelo, we...

Biohacking is a mindset – and not what you might think

Talking exclusively with the UK’s leading biohacker about Longevity, biomarkers and techniques. One of the keynote speakers at this week’s Biohacking Congress in London is...

Epigenetic age-testing market hots up

Company behind myDNAge is already profitable and promoting epigenetic tests to monitor lifestyle interventions for increased Longevity. When it comes to biological age measurement, genetic...

New Longevity event to debut in Croatia

Aging2.0 announces inaugural VOLTAGE event, connecting entrepreneurs and innovators to build a single market for active and healthy aging in Europe. This April, Aging2.0 will...

APPG for Longevity aims for parity in healthspan AND lifespan

UK All-Party Parliamentary Group (APPG) for Longevity pushes for action to remedy health equality as aging population stretches National Health Service. Time for a...

From health span to wealth span

Longevity industry expert Margaretta Colangelo says we are on the brink of a Longevity financial revolution. With people living longer and healthier lives than ever...

Functional age biomarker tracking goes digital

AgeMeter brings physical age measurement into the 21st century. With the recent explosion in direct-to-consumer genetic testing kits and services, the measurement of our functional...

J&J enters Longevity market with “Immorbidity” play

A new competition aims to find the next great breakthrough to help us stay active and healthy beyond the age of 100. People are living...

Latest articles

COVID-19: Leading clinician calls for focus on the biology of aging

Dr Nir Barzilai predicts that rapamycin could decrease severity of coronavirus in the elderly by 50%. When it comes to the world of Longevity and...

Global investment consortium slated to back Telocyte into Phase 1

Telomerase therapy ready for human Alzheimer’s trials. “There have been more than 400 registered trials for Alzheimer's and, by global consensus, every single one has...

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Telomeres on repeat to inhibit inflamm-aging

Coming around again – Italian team hopes to use repeated nucleobases to delay aging through extending telomeres. Inflammation is a double-edged sword; while it is necessary...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.